Precision Cancer Modeling

Precision Cancer Modeling (PCM) has been established primarily to enable well-designed, scientifically sound preclinical studies for drug development. We are experienced in utilizing standard as well as custom designed in vivo cancer models best suited for pharmacological evaluation of experimental therapies. 

At the center, we are constantly characterizing and validating cancer models which are kept in a ready state for application in investigation of experimental therapeutic approaches targeting cancer and related pathologies. These cancer models can be utilized for investigation of anti cancer drugs in monotherapy or combination therapy settings.

PCM can organize and carry-out a full suite of preclinical evaluation of the drug candidates of interest which typically involves: Toxicology (Tox), Pharmacokinetics (PK), and Pharmacodynamics (PD) studies. The experiments can be highly customized to suit the candidate drug.

The PCM will be your collaborator in generating high quality data for academic publications as well data packages for regulatory applications and commercial development. PCM runs small animal imaging facilities at the medical school and the West Campus consisting of clusters of in vivo imaging systems consisting of bioluminescence, fluorescence, X-ray capable IVISes and a high-resolution MRI.